ORBIMED ADVISORS LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$4.66B
Signature - Title
Sven H. Borho - Member
Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 108 $4.66B +$353M -$624M -$271M LLY, EWTX, BSX, ISRG, BIIB 13F-HR 8/14/2024, 04:06 PM
Q1 2024 109 $5.06B +$671M -$958M -$287M LLY, EWTX, BSX, ISRG, BIIB 13F-HR 5/15/2024, 04:12 PM
Q4 2023 107 $4.62B +$472M -$837M -$365M BIIB, LLY, BSX, ISRG, EWTX 13F-HR 2/14/2024, 04:14 PM
Q3 2023 146 $4.32B +$595M -$758M -$163M BSX, HUM, ISRG, BIIB, BMRN 13F-HR 11/14/2023, 04:14 PM
Q2 2023 141 $5.11B +$681M -$519M +$161M ISRG, ELVN, BSX, THRX, BIIB 13F-HR 8/14/2023, 05:25 PM
Q1 2023 123 $5.04B +$786M -$402M +$384M SVA, ELVN, BSX, HUM, BMY 13F-HR 5/15/2023, 04:41 PM
Q4 2022 114 $5.18B +$449M -$292M +$157M SVA, UNH, BMY, BSX, HUM 13F-HR 2/14/2023, 03:07 PM
Q3 2022 128 $4.93B +$687M -$320M +$367M BMY, HUM, SWTX, BSX, BMRN 13F-HR 11/14/2022, 03:11 PM
Q2 2022 142 $5.11B +$279M -$319M -$40.1M BMY, HUM, HZNP, BSX, TPTX 13F-HR 8/15/2022, 04:31 PM
Q1 2022 143 $6.13B +$696M -$509M +$187M SWTX, HZNP, BSX, PFE, THRX 13F-HR 5/16/2022, 04:17 PM
Q4 2021 156 $7.56B +$983M -$650M +$333M SWTX, BMY, HZNP, BSX, THRX 13F-HR 2/14/2022, 03:29 PM
Q3 2021 167 $9.09B +$1.03B -$821M +$208M SWTX, PRLD, HZNP, MRK, BMY 13F-HR 11/15/2021, 04:05 PM
Q2 2021 154 $9.79B +$959M -$635M +$323M SWTX, BMY, EWTX, BSX, MRK 13F-HR 8/16/2021, 04:14 PM
Q1 2021 152 $10.6B +$2.46B -$2B +$461M SWTX, EWTX, PRLD, SPRY, HZNP 13F-HR 5/17/2021, 04:16 PM
Q4 2020 148 $11.4B +$2.23B -$591M +$1.64B PRLD, SWTX, PMVP, SPRY, ABCL 13F-HR 2/16/2021, 03:43 PM
Q3 2020 139 $7.81B +$1.72B -$353M +$1.36B PRLD, SWTX, PMVP, ALXN, TPTX 13F-HR 11/16/2020, 03:12 PM
Q2 2020 134 $7.08B +$1.13B -$722M +$404M SWTX, TCDAQ, ALXN, ASND, PRVL 13F-HR 8/14/2020, 04:54 PM
Q1 2020 142 $5.95B +$1.52B -$619M +$898M ASND, TCDAQ, ALEC, SWTX, MRK 13F-HR 5/15/2020, 04:25 PM
Q4 2019 135 $6.99B +$1.1B -$671M +$432M ASND, THOR, TCDAQ, SWTX, PRVL 13F-HR 2/14/2020, 03:27 PM
Q3 2019 114 $5.23B +$568M -$533M +$34.5M ASND, TCDAQ, BSX, ALEC, PRVL 13F-HR 11/14/2019, 03:09 PM
Q2 2019 127 $6.44B +$965M -$308M +$657M ASND, TCDAQ, BSX, ALXN, ALEC 13F-HR 8/14/2019, 04:57 PM
Q1 2019 124 $6.46B +$1.17B -$796M +$372M ASND, TCDAQ, CMTA, ALXN, ALEC 13F-HR 5/15/2019, 04:24 PM
Q4 2018 131 $5.41B +$705M -$1.06B -$350M TCDAQ, ASND, BIIB, CELG, BSX 13F-HR 2/14/2019, 03:35 PM
Q3 2018 148 $8.3B +$1.05B -$1.11B -$57.4M ALXN, TCDAQ, BIIB, VRTX, BSX 13F-HR 11/14/2018, 03:07 PM
Q2 2018 146 $8.37B +$1.5B -$1.11B +$392M ALXN, BIIB, TCDAQ, BSX, VRTX 13F-HR 8/14/2018, 04:01 PM
Q1 2018 141 $8.07B +$1.8B -$11.6B -$9.84B ALXN, REGN, VRTX, MRK, BIIB 13F-HR 5/15/2018, 04:14 PM
Q4 2017 130 $7.78B +$522M -$2.19B -$1.67B BIIB, ALXN, REGN, CELG, VRTX 13F-HR 2/14/2018, 03:31 PM
Q3 2017 143 $10.5B +$1.12B -$539M +$577M ALXN, BIIB, CELG, BSX, MRK 13F-HR 11/14/2017, 04:19 PM
Q2 2017 138 $9.54B +$1.5B -$689M +$809M ALXN, CELG, BIIB, BSX, MRK 13F-HR 8/14/2017, 04:27 PM
Q1 2017 136 $8.82B +$1.06B -$775M +$289M ALXN, BIIB, CELG, BSX, MRK 13F-HR 5/15/2017, 04:17 PM
Q4 2016 131 $7.85B +$1.24B -$752M +$486M ALXN, BIIB, CELG, BSX, AMGN 13F-HR 2/14/2017, 03:25 PM
Q3 2016 139 $8.76B +$1.15B -$2.12B -$967M BIIB, BSX, AMGN, ALXN, CELG 13F-HR 11/14/2016, 03:27 PM
Q2 2016 137 $9.58B +$1.27B -$1.08B +$187M BSX, AMGN, ABBV, BMY, BIIB 13F-HR 8/15/2016, 04:16 PM
Q1 2016 140 $9.5B +$1.09B -$539M +$553M BMY, HCA, AMGN, BSX, ABBV 13F-HR 5/16/2016, 04:20 PM
Q4 2015 129 $11B +$1.32B -$697M +$623M BMY, AMGN, BSX, AGN, BIIB 13F-HR 2/16/2016, 03:24 PM
Q3 2015 130 $9.9B +$1.13B -$575M +$556M BMY, HCA, AMGN, BSX, AGN Restatement 11/18/2015, 03:02 PM
Q2 2015 1 $1.66M BONE New Holdings 8/20/2015, 02:30 PM
Q2 2015 136 $11.9B +$2.37B -$1.01B +$1.36B BIIB, BMY, AGN, HCA, ABBV 13F-HR 8/14/2015, 04:22 PM
Q1 2015 135 $11.7B +$1.62B -$1.03B +$585M BMY, BIIB, AMGN, B108PS, CELG 13F-HR 5/15/2015, 04:31 PM
Q4 2014 131 $10.5B +$1.09B -$439M +$655M BIIB, BMY, AMGN, CELG, GILD 13F-HR 2/13/2015, 03:13 PM
Q3 2014 128 $9.4B +$1.98B -$543M +$1.44B GILD, BIIB, BMY, AMGN, ICPT 13F-HR 11/14/2014, 03:15 PM
Q2 2014 131 $8.48B +$1.13B -$587M +$540M ICPT, BMY, BIIB, ABBV, GILD 13F-HR 8/14/2014, 04:23 PM
Q1 2014 139 $8.12B +$1.38B -$774M +$606M ICPT, GILD, BIIB, BMY, RLYP 13F-HR 5/15/2014, 04:26 PM
Q4 2013 119 $6.79B GILD, BIIB, CELG, BMY, AMGN 13F-HR 2/14/2014, 03:25 PM